van Gilst WH - Search Results

1

Functional antagonism of different angiotensin II type I receptor blockers in human arteries.

Wagenaar LJ, Voors AA, Buikema H, van Buiten A, Lübeck RH, Boonstra PW, van Veldhuisen DJ, van Gilst WH. Wagenaar LJ, et al. Among authors: van gilst wh, van buiten a, van veldhuisen dj. Cardiovasc Drugs Ther. 2002 Jul;16(4):311-6. doi: 10.1023/a:1021729909456. Cardiovasc Drugs Ther. 2002. PMID: 12652100

2

Differences between angiotensin-converting enzyme inhibition and angiotensin II-AT1 antagonism on angiotensin-mediated responses in human internal mammary arteries.

Voors AA, Oosterga M, Buikema H, Mariani M, Grandjean JG, van Gilst WH. Voors AA, et al. Among authors: van gilst wh. J Cardiovasc Pharmacol. 2003 Feb;41(2):178-84. doi: 10.1097/00005344-200302000-00005. J Cardiovasc Pharmacol. 2003. PMID: 12548077

3

Sertraline causes strong coronary vasodilation: possible relevance for cardioprotection by selective serotonin reuptake inhibitors.

van Melle JP, Buikema H, van den Berg MP, van Buiten A, van Veldhuisen DJ, Boonstra PW, van Gilst WH. van Melle JP, et al. Among authors: van gilst wh, van buiten a, van den berg mp, van veldhuisen dj. Cardiovasc Drugs Ther. 2004 Nov;18(6):441-7. doi: 10.1007/s10557-004-6221-3. Cardiovasc Drugs Ther. 2004. PMID: 15770431

4

Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.

Voors AA, de Kam PJ, van den Berg MP, Borghi C, Hochman JS, van Veldhuisen DJ, van Gilst WH. Voors AA, et al. Among authors: van gilst wh, van den berg mp, van veldhuisen dj. Cardiovasc Drugs Ther. 2005 Mar;19(2):119-24. doi: 10.1007/s10557-005-0444-9. Cardiovasc Drugs Ther. 2005. PMID: 16025230 Clinical Trial.

5

High angiotensin II responsiveness is associated with decreased endothelium-dependent relaxation in human arteries.

Voors AA, van Geel PP, Buikema H, Oosterga M, van Veldhuisen DJ, van Gilst WH. Voors AA, et al. Among authors: van gilst wh, van geel pp, van veldhuisen dj. J Renin Angiotensin Aldosterone Syst. 2005 Dec;6(3):145-50. doi: 10.3317/jraas.2005.021. J Renin Angiotensin Aldosterone Syst. 2005. PMID: 16525945 Free article.

6

The current role of ACE-inhibitors for secondary prevention in cardiovascular disease; from pathogenesis to clinical practice.

Voors AA, van Veldhuisen DJ, van Gilst WH. Voors AA, et al. Among authors: van gilst wh, van veldhuisen dj. Cardiovasc Drugs Ther. 2006 Feb;20(1):69-73. doi: 10.1007/s10557-006-6570-1. Cardiovasc Drugs Ther. 2006. PMID: 16619108 Review. No abstract available.

7

Effects of C-reactive protein and cholesterol on responsiveness in vitro of the internal thoracic artery to angiotensin II in patients having coronary artery bypass grafting.

van der Harst P, Asselbergs FW, Buikema H, Voors AA, van Veldhuisen DJ, van Gilst WH. van der Harst P, et al. Among authors: van gilst wh, van veldhuisen dj. Am J Cardiol. 2006 Sep 15;98(6):751-3. doi: 10.1016/j.amjcard.2006.04.010. Epub 2006 Jul 26. Am J Cardiol. 2006. PMID: 16950177

8

Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery.

Voors AA, Oosterga M, Buikema H, May JF, Grandjean JG, van Buiten A, van Gilst WH. Voors AA, et al. Among authors: van gilst wh, van buiten a. Cardiovasc Res. 1997 Jun;34(3):568-74. doi: 10.1016/s0008-6363(97)00081-3. Cardiovasc Res. 1997. PMID: 9231040

9

Dual pathway for angiotensin II formation in human internal mammary arteries.

Voors AA, Pinto YM, Buikema H, Urata H, Oosterga M, Rooks G, Grandjean JG, Ganten D, van Gilst WH. Voors AA, et al. Among authors: van gilst wh. Br J Pharmacol. 1998 Nov;125(5):1028-32. doi: 10.1038/sj.bjp.0702150. Br J Pharmacol. 1998. PMID: 9846641 Free PMC article.

10

Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries.

van Geel PP, Pinto YM, Voors AA, Buikema H, Oosterga M, Crijns HJ, van Gilst WH. van Geel PP, et al. Among authors: van gilst wh. Hypertension. 2000 Mar;35(3):717-21. doi: 10.1161/01.hyp.35.3.717. Hypertension. 2000. PMID: 10720584 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters